Javascript must be enabled to continue!
Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane
View through CrossRef
The topology of carnitine palmitoyltransferase I (CPT I) in the outer membrane of rat liver mitochondria was studied using several approaches. 1. The accessibility of the active site and malonyl-CoA-binding site of the enzyme from the cytosolic aspect of the membrane was investigated using preparations of octanoyl-CoA and malonyl-CoA immobilized on to agarose beads to render them impermeant through the outer membrane. Both immobilized ligands were fully able to interact effectively with CPT I. 2. The effects of proteinase K and trypsin on the activity and malonyl-CoA sensitivity of CPT I were studied using preparations of mitochondria that were either intact or had their outer membranes ruptured by hypo-osmotic swelling (OMRM). Proteinase K had a marked but similar effect on CPT I activity irrespective of whether only the cytosolic or both sides of the membrane were exposed to it. However, it affected sensitivity more rapidly in OMRM. By contrast, trypsin only reduced CPT I activity when incubated with OMRM. The sensitivity of the residual CPT I activity was unaffected by trypsin. 3. The proteolytic fragments generated by these treatments were studied by Western blotting using three anti-peptide antibodies raised against linear epitopes of CPT I. These showed that a proteinase K-sensitive site close to the N-terminus was accessible from the cytosolic side of the membrane. No trypsin-sensitive sites were accessible in intact mitochondria. In OMRM, both proteinase K and trypsin acted from the inter-membrane space side of the membrane. 4. The ability of intact mitochondria and OMRM to bind to each of the three anti-peptide antibodies was used to study the accessibility of the respective epitopes on the cytosolic and inter-membrane space sides of the membrane. 5. The results of all these approaches indicate that CPT I adopts a bitopic topology within the mitochondrial outer membrane; it has two transmembrane domains, and both the N- and C-termini are exposed on the cytosolic side of the membrane, whereas the linker region between the transmembrane domains protrudes into the intermembrane space.
Title: Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane
Description:
The topology of carnitine palmitoyltransferase I (CPT I) in the outer membrane of rat liver mitochondria was studied using several approaches.
1.
The accessibility of the active site and malonyl-CoA-binding site of the enzyme from the cytosolic aspect of the membrane was investigated using preparations of octanoyl-CoA and malonyl-CoA immobilized on to agarose beads to render them impermeant through the outer membrane.
Both immobilized ligands were fully able to interact effectively with CPT I.
2.
The effects of proteinase K and trypsin on the activity and malonyl-CoA sensitivity of CPT I were studied using preparations of mitochondria that were either intact or had their outer membranes ruptured by hypo-osmotic swelling (OMRM).
Proteinase K had a marked but similar effect on CPT I activity irrespective of whether only the cytosolic or both sides of the membrane were exposed to it.
However, it affected sensitivity more rapidly in OMRM.
By contrast, trypsin only reduced CPT I activity when incubated with OMRM.
The sensitivity of the residual CPT I activity was unaffected by trypsin.
3.
The proteolytic fragments generated by these treatments were studied by Western blotting using three anti-peptide antibodies raised against linear epitopes of CPT I.
These showed that a proteinase K-sensitive site close to the N-terminus was accessible from the cytosolic side of the membrane.
No trypsin-sensitive sites were accessible in intact mitochondria.
In OMRM, both proteinase K and trypsin acted from the inter-membrane space side of the membrane.
4.
The ability of intact mitochondria and OMRM to bind to each of the three anti-peptide antibodies was used to study the accessibility of the respective epitopes on the cytosolic and inter-membrane space sides of the membrane.
5.
The results of all these approaches indicate that CPT I adopts a bitopic topology within the mitochondrial outer membrane; it has two transmembrane domains, and both the N- and C-termini are exposed on the cytosolic side of the membrane, whereas the linker region between the transmembrane domains protrudes into the intermembrane space.
Related Results
Carnitine Inborn Errors of Metabolism
Carnitine Inborn Errors of Metabolism
Carnitine plays essential roles in intermediary metabolism. In non-vegetarians, most of carnitine sources (~75%) are obtained from diet whereas endogenous synthesis accounts for ar...
SGMS1-AS1/MicroRNA-106a-5p/CPT2 Axis as a Novel Target for Regulating Lactate Metabolism in Colon Cancer
SGMS1-AS1/MicroRNA-106a-5p/CPT2 Axis as a Novel Target for Regulating Lactate Metabolism in Colon Cancer
Purpose The malignant transformation of cells can lead to aerobic glycolysis, an important form of metabolic reprogramming in colon cancer cells, which can cause the accumulation o...
Role of carnitine in regulation of hypoglycemia-induced hypertension and cardiac hypertrophy
Role of carnitine in regulation of hypoglycemia-induced hypertension and cardiac hypertrophy
Abstract
Background: Cardiovascular disease is a leading cause of death in diabetic patients. Hyperglycemia and iatrogenic hypoglycemia exacerbate several pathogenic mechan...
Progression of Cisplatin-Induced Nephrotoxicity in a Carnitine-Depleted Rat Model
Progression of Cisplatin-Induced Nephrotoxicity in a Carnitine-Depleted Rat Model
<i>Background:</i> This study has been initiated to investigate whether endogenous carnitine depletion and/or carnitine deficiency is an additional risk factor and/or a...
Impact of haemodialysis on plasma carnitine concentrations in haemodialysis patients
Impact of haemodialysis on plasma carnitine concentrations in haemodialysis patients
Objective: To evaluate the impact of haemodialysis on plasma carnitine levels.
Method: The cross-sectional study was conducted from April 20, 2020 to May 10, 2022, at the dialysis ...
Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?
Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?
l-Carnitine is an amino acid derivative widely known for its involvement in the transport of long-chain fatty acids into the mitochondrial matrix, where fatty acid oxidation occurs...
Increasing Skeletal Muscle Carnitine Availability During High Intensity Interval Training
Increasing Skeletal Muscle Carnitine Availability During High Intensity Interval Training
Increasing skeletal muscle carnitine availability increases pyruvate dehydrogenase (PDC) flux during continuous exercise at 80% maximal aerobic capacity (VO
2
...
Procedure for Western blot v1
Procedure for Western blot v1
Goal: This document has the objective of standardizing the protocol for Western blot. This technique allows the detection of specific proteins separated on polyacrylamide gel and t...

